Skip to main content

Table 1 Correlation between MYO18B expression and clinical characteristics in patients with hepatocellular carcinoma

From: MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway

Characteristics

Expression of MYO18B

P value

Low

High

Age

  

0.361

 < 60

18

14

 

 ≥ 60

22

26

 

Gender

  

0.260

 Female

20

15

 

 male

20

25

 

Grade

  

1.000

 G1 + G2

26

26

 

 G3 + G4

14

14

 

Pathologic-Stage

  

0.025

 I + II

24

14

 

 III + IV

16

26

 

Pathologic-T

  

0.014

 T1 + T2

26

15

 

 T3 + T4

14

25

 

Pathologic-N

  

1.000

 N0

37

36

 

 N1

3

4

 

Pathologic-M

  

1.000

 M0

39

38

 

 M1

1

2

 
  1. T tumor status, N regional lymph node status, M metastasis status
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us